WinstonWınston
Back
Stock

Universal Health Services

UHS
70
Medical - Care Facilities · Healthcare
Also trades as: 0LJL.L GBP 1.89 (+1.05%)
Price
$186.89
-1.24 (-0.66%)
Market Cap
$11.01B
Winston Score
70
Winston is happy
A high-quality business with solid fundamentals.
Data as of Oct 23, 2026 · filings through Jun 30, 2026

§How the score breaks down

Quality
Strong
21/30
Growth
Exceptional
18/20
Cash Flow
Strong
7/10
Stability
Strong
7/10
Valuation
Good
6/10
Ownership
Good
10/15
Dividends
Weak
1/5

70 of 100 counted points = Winston Score 70.

Track this stock — start free trial

Share count falling — buybacks

−23.0% over 4y

The company has reduced its share count over this period, returning value to shareholders through buybacks.

Diluted shares outstanding: 83.7M (2021) → 64.5M (2025)

§Winston Score History

The full picture

Universal Health Services owns and operates hospitals and behavioral health centers across the United States. It runs two main types of facilities: acute care hospitals, which treat serious medical conditions and emergencies, and behavioral health facilities, which help patients with mental health and substance abuse issues. UHS is one of the largest for-profit hospital operators in the country.

The company makes money by charging patients, insurance companies, and government programs like Medicare and Medicaid for medical services. UHS operates roughly 400 facilities, mostly in the U.S., with a smaller presence in the U.K. Its scale gives it some negotiating power with insurers and suppliers, which helps protect margins. The behavioral health segment has been a steady growth area, but the company faces ongoing pressure from rising labor costs and its heavy reliance on government reimbursement rates, which can change with policy shifts.

Politician Trades

8 trades / 12mo

3 Congressional buys and 5 sells on UHS in the last 12 months.

Unlock the full Smart Money Map — every trade plotted on the price chart with politicians, amounts and returns since each trade. Founder's Deal is $57/mo locked for life.

Unlock politician trades

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+8.3% YoY

YoY Growth Rate

Slow revenue growth

Reported EPS Growth

+9.5% YoY

Quarterly reporting periods ended:

30 Jun 2025: $5.49

30 Jun 2026: $6.01

Reported/statutory EPS, not adjusted or underlying earnings. One-off items can affect this figure. Provider rounding can affect the growth rate.

YoY Growth Rate

Reported EPS increased year over year

R&D Spend

$0/ year

0.0% of revenue

Below sector average (18%)

Research and development spending

Insider Activity

16.8%ownership

→ Flat

Insider ownership roughly steady over the past year

Cash Position

Cash flow positive

$139M cash & investments

Quarterly Free Cash Flow

↑ Burn rate improving

Company generates more cash than it spends — no dilution risk from fundraising

Growth context

Universal Health Services is growing revenue at 8% year-over-year. The Winston Score measures business quality today — these growth metrics show what could matter tomorrow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
90.9%
Premium pricing power — 90.9% gross margin
Profit after running costs
Operating Margin
11.1%
Modest — 11.1% operating margin
Return on the money invested
ROCE
16.1%
Strong — 16.1% return on capital

ROIC between 15% and 25%. Every dollar invested in the business earns 15 to 25 cents back per year.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
+10.0%
Steady sales growth (+10.0% YoY)
Profit growth
EPS YoY
+27.6%
Earnings growing fast (+27.6% YoY)

Earnings growing 25%+ a year. The compounder zone.

How steady the profit is
EPS Consistency
8/8 quarters
Every recent quarter grew earnings vs last year

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
118%
Turns 118% of profit into real cash
Spare cash per sale
FCF Margin
4.6%
Thin free cash flow (4.6%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
0.70
Moderate — manageable debt (0.70)
Covers its interest
Interest Cover
13.22x
Comfortably covers interest (13.2x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
7.6x
Attractive valuation — P/E 7.6

P/E under 10. The price tag is small relative to last year's profit.

Cheaper or dearer next year
P/E vs Forward
-0.2
SLOWING
Earnings expected to fall — forward P/E higher than today

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend
Dividend Yield
0.45%
Small dividend — 0.45% yield

Modest yield. The bulk of any return needs to come from price appreciation.

Dividend record
Dividend Growth
+0.0%
Dividend flat
Payout Ratio
3%
no trend
Pays out a modest share of profit and keeps the rest to reinvest. Room to keep paying through a weak year.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial